Diabetes-induced Neuropathic Mechanical Hyperalgesia Depends on P2X4 Receptor Activation in Dorsal Root Ganglia
- PMID: 30537520
- DOI: 10.1016/j.neuroscience.2018.12.003
Diabetes-induced Neuropathic Mechanical Hyperalgesia Depends on P2X4 Receptor Activation in Dorsal Root Ganglia
Abstract
Peripheral diabetic neuropathy (PDN) manifests in 50-60% of type I and II diabetic patients and is the major cause of limb amputation. Adequate therapy for PDN is a current challenge. There are evidences that the activation of the P2X4 receptor (P2X4R) expressed on microglial cells of the central nervous system takes part in the development of neuropathic pain. However, there is an open question: Is P2X4R activation on dorsal root ganglia (DRG) involved in the development of neuropathic pain? To answer this question, this study verified the involvement of P2X4R expressed in DRG cells on diabetes-induced neuropathic mechanical hyperalgesia in rats. We found that intrathecal or ganglionar (L5-DRG) administration of a novel P2X4R antagonist (PSB-15417) or intrathecal administration of oligodeoxynucleotides (ODN)-antisense against the P2X4R reversed diabetes-induced neuropathic mechanical hyperalgesia. The DRG of the diabetic neuropathic rats showed an increase in P2X4R expression, and the DRG immunofluorescence suggested that P2X4R is expressed mainly in satellite glial cells (SGC). Finally, our study showed a functional expression of P2X4R in SGCs of the rat's DRG, because the P2X4R agonist BzATP elicits an increase in intracellular calcium concentration in SGCs, which was reduced by PSB-15417. These findings indicate that P2X4R activation in DRG is essential to diabetes-induced neuropathic mechanical hyperalgesia. Therefore, this purinergic receptor in DRG could be an interesting therapeutic target for quaternary P2X4R antagonists that do not cross the hematoencephalic barrier, for the control of neuropathic pain, preserving central nervous system functions.
Keywords: P2X4 receptor; dorsal root ganglion; mechanical hyperalgesia; peripheral diabetic neuropathy; satellite glial cells; streptozotocin.
Copyright © 2018 IBRO. Published by Elsevier Ltd. All rights reserved.
Similar articles
-
Osthole alleviated diabetic neuropathic pain mediated by the P2X4 receptor in dorsal root ganglia.Brain Res Bull. 2018 Sep;142:289-296. doi: 10.1016/j.brainresbull.2018.08.008. Epub 2018 Aug 14. Brain Res Bull. 2018. PMID: 30118750
-
Quercetin relieved diabetic neuropathic pain by inhibiting upregulated P2X4 receptor in dorsal root ganglia.J Cell Physiol. 2019 Mar;234(3):2756-2764. doi: 10.1002/jcp.27091. Epub 2018 Aug 26. J Cell Physiol. 2019. PMID: 30145789
-
Evaluation of the neonatal streptozotocin model of diabetes in rats: Evidence for a model of neuropathic pain.Pharmacol Rep. 2018 Apr;70(2):294-303. doi: 10.1016/j.pharep.2017.09.002. Epub 2017 Sep 14. Pharmacol Rep. 2018. PMID: 29477037 Free PMC article.
-
[Green Pharma: A New Strategy for Drug Discovery in Academia by Targeting Glial Cells and ATP Receptors].Yakugaku Zasshi. 2018;138(8):1027-1031. doi: 10.1248/yakushi.17-00211-1. Yakugaku Zasshi. 2018. PMID: 30068843 Review. Japanese.
-
Microglia in Neuropathic Pain.Adv Neurobiol. 2024;37:399-403. doi: 10.1007/978-3-031-55529-9_22. Adv Neurobiol. 2024. PMID: 39207704 Review.
Cited by
-
Pyridoxamine alleviates mechanical allodynia by suppressing the spinal receptor for advanced glycation end product-nuclear factor-κB/extracellular signal-regulated kinase signaling pathway in diabetic rats.Mol Pain. 2020 Jan-Dec;16:1744806920917251. doi: 10.1177/1744806920917251. Mol Pain. 2020. PMID: 32252594 Free PMC article.
-
The Nociceptor Primary Cilium Contributes to Mechanical Nociceptive Threshold and Inflammatory and Neuropathic Pain.J Neurosci. 2024 Nov 20;44(47):e1265242024. doi: 10.1523/JNEUROSCI.1265-24.2024. J Neurosci. 2024. PMID: 39349056 Free PMC article.
-
Update of P2X receptor properties and their pharmacology: IUPHAR Review 30.Br J Pharmacol. 2021 Feb;178(3):489-514. doi: 10.1111/bph.15299. Epub 2020 Dec 21. Br J Pharmacol. 2021. PMID: 33125712 Free PMC article. Review.
-
Preparation and preliminary evaluation of a tritium-labeled allosteric P2X4 receptor antagonist.Purinergic Signal. 2024 Dec;20(6):645-656. doi: 10.1007/s11302-024-10005-2. Epub 2024 May 25. Purinergic Signal. 2024. PMID: 38795223 Free PMC article.
-
Recommended tool compounds and drugs for blocking P2X and P2Y receptors.Purinergic Signal. 2021 Dec;17(4):633-648. doi: 10.1007/s11302-021-09813-7. Epub 2021 Sep 2. Purinergic Signal. 2021. PMID: 34476721 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical